Cargando…

Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy

Background: Gender dysphoria is defined as a feeling of distress resulting from the incongruence between the gender assigned at birth and the identity gender and lasting longer than 6 months. In individuals with gender dysphoria, gender-affirming hormone therapy(GAHT) may improve quality of life (Qo...

Descripción completa

Detalles Bibliográficos
Autores principales: Da Silva, Eliane Dias, Fighera, Tayane Muniz, Allgayer, Roberta Martins Costa Moreira, Lobato, Maria Inês Rodrigues, Spritzer, Poli Mara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089853/
http://dx.doi.org/10.1210/jendso/bvab048.1616
_version_ 1783687139216588800
author Da Silva, Eliane Dias
Fighera, Tayane Muniz
Allgayer, Roberta Martins Costa Moreira
Lobato, Maria Inês Rodrigues
Spritzer, Poli Mara
author_facet Da Silva, Eliane Dias
Fighera, Tayane Muniz
Allgayer, Roberta Martins Costa Moreira
Lobato, Maria Inês Rodrigues
Spritzer, Poli Mara
author_sort Da Silva, Eliane Dias
collection PubMed
description Background: Gender dysphoria is defined as a feeling of distress resulting from the incongruence between the gender assigned at birth and the identity gender and lasting longer than 6 months. In individuals with gender dysphoria, gender-affirming hormone therapy(GAHT) may improve quality of life (QoL). Objectives: Here, we aimed to assess perceived QoL and possible contributing factors in a sample of transgender women and transgender men using GAHT. Methods: In this cross-sectional study, transgender women and men were recruited by availability sampling from a national transgender health service. Individuals over 18 years old with a confirmed diagnosis of gender dysphoria receiving medically prescribed GAHT for at least 6 months were consecutively included. Also included were trans men who had undergone mastectomy and trans women who had received breast augmentation surgery. Individuals who had undergone gender affirmation surgery (specifically genital surgery) or with uncontrolled clinical/psychiatric conditions at the time of the initial assessment were excluded. Sociodemographic, physical, and hormone data were collected from all participants. The WHOQOL-BREF questionnaire was used to evaluate QoL. A total of 135 transgender individuals were invited. Seventeen individuals with previous genital surgery (12.6%) and five who refused to participate (3.7%) were excluded. Therefore, 113 patients were enrolled in the study (60 trans women and 53 trans men). Results: There was no significant difference in QoLbetween the groups. In trans women, greater breast development and stable relationships, and higher body mass index were associated with higher QoLdomain scores. In trans men, higher domain scores were found in individuals with a stable relationship, increased body hair, physical activity practice, and being employed. Conclusion: Data from this study suggest that GAHT-related physical characteristics are associated with higher QoLscores, and that sociodemographic parameters may impact these associations. Healthcare providers might consider these factors when planning interventions to improve QoLin transgender individuals.
format Online
Article
Text
id pubmed-8089853
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-80898532021-05-06 Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy Da Silva, Eliane Dias Fighera, Tayane Muniz Allgayer, Roberta Martins Costa Moreira Lobato, Maria Inês Rodrigues Spritzer, Poli Mara J Endocr Soc Reproductive Endocrinology Background: Gender dysphoria is defined as a feeling of distress resulting from the incongruence between the gender assigned at birth and the identity gender and lasting longer than 6 months. In individuals with gender dysphoria, gender-affirming hormone therapy(GAHT) may improve quality of life (QoL). Objectives: Here, we aimed to assess perceived QoL and possible contributing factors in a sample of transgender women and transgender men using GAHT. Methods: In this cross-sectional study, transgender women and men were recruited by availability sampling from a national transgender health service. Individuals over 18 years old with a confirmed diagnosis of gender dysphoria receiving medically prescribed GAHT for at least 6 months were consecutively included. Also included were trans men who had undergone mastectomy and trans women who had received breast augmentation surgery. Individuals who had undergone gender affirmation surgery (specifically genital surgery) or with uncontrolled clinical/psychiatric conditions at the time of the initial assessment were excluded. Sociodemographic, physical, and hormone data were collected from all participants. The WHOQOL-BREF questionnaire was used to evaluate QoL. A total of 135 transgender individuals were invited. Seventeen individuals with previous genital surgery (12.6%) and five who refused to participate (3.7%) were excluded. Therefore, 113 patients were enrolled in the study (60 trans women and 53 trans men). Results: There was no significant difference in QoLbetween the groups. In trans women, greater breast development and stable relationships, and higher body mass index were associated with higher QoLdomain scores. In trans men, higher domain scores were found in individuals with a stable relationship, increased body hair, physical activity practice, and being employed. Conclusion: Data from this study suggest that GAHT-related physical characteristics are associated with higher QoLscores, and that sociodemographic parameters may impact these associations. Healthcare providers might consider these factors when planning interventions to improve QoLin transgender individuals. Oxford University Press 2021-05-03 /pmc/articles/PMC8089853/ http://dx.doi.org/10.1210/jendso/bvab048.1616 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Reproductive Endocrinology
Da Silva, Eliane Dias
Fighera, Tayane Muniz
Allgayer, Roberta Martins Costa Moreira
Lobato, Maria Inês Rodrigues
Spritzer, Poli Mara
Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
title Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
title_full Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
title_fullStr Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
title_full_unstemmed Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
title_short Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
title_sort physical and sociodemographic features associated with quality of life in transgender individuals using gender-affirming hormone therapy
topic Reproductive Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089853/
http://dx.doi.org/10.1210/jendso/bvab048.1616
work_keys_str_mv AT dasilvaelianedias physicalandsociodemographicfeaturesassociatedwithqualityoflifeintransgenderindividualsusinggenderaffirminghormonetherapy
AT figheratayanemuniz physicalandsociodemographicfeaturesassociatedwithqualityoflifeintransgenderindividualsusinggenderaffirminghormonetherapy
AT allgayerrobertamartinscostamoreira physicalandsociodemographicfeaturesassociatedwithqualityoflifeintransgenderindividualsusinggenderaffirminghormonetherapy
AT lobatomariainesrodrigues physicalandsociodemographicfeaturesassociatedwithqualityoflifeintransgenderindividualsusinggenderaffirminghormonetherapy
AT spritzerpolimara physicalandsociodemographicfeaturesassociatedwithqualityoflifeintransgenderindividualsusinggenderaffirminghormonetherapy